Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters
A Multi-centric Trial to Evaluate the Efficacy of Electronic-Based Psychosocial Interventions on Future Suicide Risk Among Adolescent Suicide Attempters
2 other identifiers
interventional
168
1 country
2
Brief Summary
Our study is designed to study the efficacy of an Electronic based psycho-social intervention targeting healthy coping and problem solving skills to mitigate suicidal behaviour. This would integrate existing systems and bridge the gap in accessibility to care for suicidal behaviour.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 18, 2024
CompletedFirst Posted
Study publicly available on registry
June 25, 2024
CompletedStudy Start
First participant enrolled
August 31, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedFebruary 9, 2026
February 1, 2026
1.6 years
June 18, 2024
February 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Persistent Suicide Ideation
Change in intervention arm as compared to TAU on persistent suicidal ideation using the Columbia Suicide Severity Rating Scale (C-SSRS). the ideation ranges from 0-5 on this scale.
At baseline and 1,3, 6 and 12 months after the baseline intervention.
Suicide attempts
Change in intervention arm as compared to TAU on number of suicide attempts. Minimum attempts can be 0 and maximum can be infinity.
At baseline and 1,3, 6 and 12 months after the baseline intervention.
Secondary Outcomes (5)
Depression
At baseline and 1,3, 6 and 12 months after the baseline intervention.
Acceptability of Intervention Measure (AIM)
At baseline and 1,3, 6 and 12 months after the baseline intervention.
Feasibility of Intervention Measure (FIM)
At baseline and 1,3, 6 and 12 months after the baseline intervention.
Attribution Style
At baseline and 1,3, 6 and 12 months after the baseline intervention.
Coping Mechanism
At baseline and 1,3, 6 and 12 months after the baseline intervention.
Study Arms (2)
Electronic Based Psychosocial Intervention (EBPSI)
EXPERIMENTALElectronic Based Psychosocial Intervention (EBPSI) described as video based telepsychiatry sessions targeted on brief intervention and coping skills; with a total of 5 sessions on days 10, 30, 45, 60 and 90 after baseline intervention.
Treatment as Usual
ACTIVE COMPARATORThe Treatment as Usual (TAU) arm shall be a telephonic regular contact: with a total of 5 reminder calls on days 10, 30, 45, 60 and 90 after baseline intervention. The session shall include a reminder for the next planned follow up session and a general query for overall wellbeing.
Interventions
Electronic based Psycho-social Intervention (EBPSI) described as video based telepsychiatry sessions targeted on brief intervention and coping skills; with a total of 5 sessions on days 10, 30, 45, 60 and 90 after baseline intervention.
Eligibility Criteria
You may qualify if:
- All adolescents who have attempted suicide within the last thirty days and presented to the study site
- Between ages of 12-18 years
- Participants of all gender will be included
- Medically stable patients who have stable blood pressure, breathing rates without fever, and intact orientation to time, place, and person
You may not qualify if:
- A current or a lifetime diagnosis of psychosis. We will confirm the same using a detailed clinical interview according to ICD-10 diagnostic guidelines.
- A history of mental retardation and any neurological condition causing cognitive impairment.
- A diagnosis of substance dependence as confirmed by M.I.N.I. KID 6.0 over the last six months. We will include those with tobacco dependence.
- A diagnosis of serious medical illness like end-stage cancer, AIDS, less than a month following acute cardiovascular and cerebrovascular events.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
St John's Medical College and Hospital
Bengaluru, Karnataka, 560034, India
Kalinga Institute of Medical Sciences (KIMS),
Bhubaneswar, Odisha, 751024, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vishwajit L Nimgaonkar, MD, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The rater will be blind to the group status of the participant.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 18, 2024
First Posted
June 25, 2024
Study Start
August 31, 2024
Primary Completion
March 31, 2026
Study Completion (Estimated)
May 31, 2026
Last Updated
February 9, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- One year after publication of the results of the study.
- Access Criteria
- For individual participant data, meta-analysis.
Individual participant data that underlie the results reported in the article, after deidentification (text, tables, figures, and appendices).